November 2020

Let's spread the word about Immunotherapy! Click to share this page with your community.

Oswald’s Partner in the Fight

November 24, 2020Caroline Offit

In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.

Read More

Filter by:

*Immunotherapy results may vary from patient to patient.